Also of concern is the risk of thyroid cancer
And it acts on appetite centers in the brain, reducing hunger and promoting satiety
Retatrutide (GLP3-R) is evaluated in laboratory research for: Its multi-pathway activity differentiates it from single-receptor GLP analog peptides studied in other research frameworks
The human liver can produce it, and it is also present in several foods
The medication has a triple action on GLP-1, GIP, and glucagon receptors, making it more effective for blood sugar control and weight loss than current medications such as semaglutide, tirzepatide, dulaglutide, and liraglutide
doi 10.1111/apt.18138 99 WildingJPBatterhamRLCalannaSDaviesMVan GaalLFLingvayIet al